BCG-assoziierte Urogenitaltuberkulose nach Harnblasenkarzinom

Rofo. 2016 Aug;188(8):782-3. doi: 10.1055/s-0042-105518. Epub 2016 Apr 19.
[Article in German]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / adverse effects
  • Adjuvants, Immunologic / therapeutic use
  • Aged
  • BCG Vaccine / adverse effects*
  • BCG Vaccine / therapeutic use*
  • Diagnosis, Differential
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Treatment Outcome
  • Tuberculosis, Urogenital / chemically induced*
  • Tuberculosis, Urogenital / diagnostic imaging*
  • Urinary Bladder Neoplasms / complications
  • Urinary Bladder Neoplasms / diagnostic imaging
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Adjuvants, Immunologic
  • BCG Vaccine